As of 2026-08-11, the Relative Valuation of PMV Pharmaceuticals Inc (PMVP) is (37.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.23 USD, the upside of PMV Pharmaceuticals Inc based on Relative Valuation is -3187.4%.
The range of the Relative Valuation is (34.26) - (40.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.3x - 27.6x | 25.8x |
| Forward P/E multiples | 22.0x - 27.9x | 25.9x |
| Fair Price | (34.26) - (40.49) | (37.97) |
| Upside | -2885.2% - -3391.6% | -3187.4% |
| Date | P/E |
| 2026-08-07 | -0.81 |
| 2026-08-06 | -0.80 |
| 2026-08-05 | -0.80 |
| 2026-08-04 | -0.80 |
| 2026-08-03 | -0.76 |
| 2026-07-31 | -0.76 |
| 2026-07-30 | -0.77 |
| 2026-07-29 | -0.73 |
| 2026-07-28 | -0.75 |
| 2026-07-27 | -0.80 |
| 2026-07-24 | -0.84 |
| 2026-07-23 | -0.91 |
| 2026-07-22 | -0.91 |
| 2026-07-21 | -0.89 |
| 2026-07-20 | -0.87 |
| 2026-07-17 | -0.91 |
| 2026-07-16 | -0.88 |
| 2026-07-15 | -0.95 |
| 2026-07-14 | -0.97 |
| 2026-07-13 | -0.87 |
| 2026-07-10 | -0.84 |
| 2026-07-09 | -0.84 |
| 2026-07-08 | -0.85 |
| 2026-07-07 | -0.84 |
| 2026-07-06 | -0.82 |
| 2026-07-02 | -0.83 |
| 2026-07-01 | -0.84 |
| 2026-06-30 | -0.91 |
| 2026-06-29 | -0.88 |
| 2026-06-26 | -0.81 |
| 2026-06-25 | -0.78 |
| 2026-06-24 | -0.80 |
| 2026-06-23 | -0.82 |
| 2026-06-22 | -0.78 |
| 2026-06-18 | -0.77 |
| 2026-06-17 | -0.75 |
| 2026-06-16 | -0.74 |
| 2026-06-15 | -0.72 |
| 2026-06-12 | -0.76 |
| 2026-06-11 | -0.74 |
| 2026-06-10 | -0.72 |
| 2026-06-09 | -0.71 |
| 2026-06-08 | -0.74 |
| 2026-06-05 | -0.76 |
| 2026-06-04 | -0.81 |
| 2026-06-03 | -0.79 |
| 2026-06-02 | -0.80 |
| 2026-06-01 | -0.84 |
| 2026-05-29 | -0.82 |
| 2026-05-28 | -0.81 |